Callum Scott

Callum Scott has 15 years’ R&D experience, including over 6 years in industry as a Development Manager. As a Technical Transfer & Formulation Development Manager with Allergy Therapeutics (UK) Ltd., Callum was responsible for all Product Development/CMC activities relating to a novel immunotherapeutic virus-like particle (VLP) vaccine for the treatment of peanut allergic patients (VLP Peanut). This led to a successful investigational new drug (IND) application and the initiation of a Phase I clinical trial. Previously a Development Manager with Benchmark Animal Health Ltd., he managed the development several vaccine projects relevant to animal health. Callum joined knoell Animal Health as a Senior Advisor in Veterinary Product Development in June 2023. He holds a PhD in Molecular Microbiology from Heriot-Watt University and is a chartered member of the Royal Society of Biology.